Kelly Kim

Manager, BD at SapiensBio

Presenter

Kelly Kim is a biotech professional with experience across drug discovery research, regulatory affairs, and global sales. She holds an Honours B.Sc. in Pharmacology & Toxicology from the University of Toronto and previously conducted research at Robert Langer Lab the M.I.T. and the Ontario Institute for Cancer Research, contributing to drug delivery and small-molecule discovery programs and co-authoring publications in journals including Nature Medicine and Science Advances. At SapiensBio, she focuses on business development as the company advances first-in-class therapies for fibrotic diseases toward clinical development and global partnerships.